ArticleCellular and molecular neurobiology2026
Early HMGB1 Inhibition Reduces Hippocampal Injury During Adolescence in a Young Mouse Model of Radiation-Induced Brain Injury.
Article in Cellular and molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Radiotherapy is a primary treatment for childhood malignant brain tumors. However, it often leads to radiation-induced brain injury (RIBI), which significantly impairs neurodevelopment in pediatric patients. Effective treatment for this complication remains limited. Given the established link between RIBI-associated neuroinflammation and HMGB1, we investigated the neuroprotective potential of early HMGB1 inhibition in a young mouse model. Four-week-old male C57BL/6 mice received a single 10 Gy whole-brain irradiation and were divided into Sham + PBS, Rad + PBS, and Rad + glycyrrhizin (GL, 10 mg/kg for 14 days post-irradiation) groups. Immunofluorescence showed that irradiation significantly triggered nuclear-to-cytoplasmic translocation of HMGB1 in hippocampus 7 days post-irradiation. Preliminary data suggests that GL administration abrogates increases in HMGB1 expression and translocation as well as of the key inflammatory receptors TLRs and RAGE. Immunofluorescence and Nissl staining confirmed that GL treatment inhibited microglial activation and mitigated neuronal loss 14 days post-irradiation. Critically, behavioral assessment via the Morris water maze 8 weeks post-irradiation showed that this early intervention significantly improved spatial learning and memory deficits. Complementary preliminary in vitro experiments demonstrate irradiation-associated increases in microglia-derived inflammatory mediators and corresponding changes in neuronal MAP2 staining following exposure to microglia-conditioned media, with altered cytokine profiles observed in the presence of GL. Collectively, our results demonstrate that early pharmacological blockade of the HMGB1 pathway alleviates microglial activation and hippocampal damage, offering a potential new treatment target for pediatric RIBI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.